Why it Matters

USA Managed Care Organization resumed lobbying after a decade-long hiatus with renewed focus and significant spending. The company shifted from monitoring healthcare reform to actively influencing federal retiree benefits policy. Since late 2022, USA MCO has spent $590,000 on lobbying through Penn Avenue Partners, marking a strategic pivot toward federal contracting opportunities.

By the Numbers

Broader Context

Congress is actively pursuing healthcare transparency reforms targeting pharmacy benefit managers and federal employee benefits. Multiple bipartisan bills address PBM oversight and contracting standards. The Federal Employees Health Benefits program serves millions of federal workers and retirees. USA Managed Care Organization operates as America’s largest privately-held PPO across 47 states.

The Agenda

USA MCO focuses specifically on “federal retiree health benefits programs” and appropriations. The company previously monitored the National Defense Authorization Act and Hospital Inpatient Services Modernization Act. Their current lobbying targets federal healthcare contracting and funding decisions. No specific pending legislation was identified as their primary focus.

Competitive Landscape

Between The Lines

The Fair Pharmacies for Federal Employees Act of 2025 (H.R. 4409) would prohibit OPM from contracting with carriers having common ownership with pharmacies. The PBM Reform Act of 2025 (H.R. 4317) sets new transparency standards for pharmacy benefit managers. Rep. Sheila Cherfilus-McCormick introduced legislation extending FEHB coverage for terminated workers with severe illnesses. The Hidden Fee Disclosure Act of 2025 (H.R. 2041) requires detailed PBM fee disclosures.

The Bottom Line

USA MCO’s strategic lobbying investment positions them for federal contracting opportunities amid congressional healthcare reforms. Their experienced team brings relevant appropriations and health policy expertise.

All data used in this article came from Legis1. Request a demo to learn more!

Spot something wrong? Report an issue with this article